Get the Stockscreener App
1.69
1.17%
-0.02
Why is Ikena Oncology Inc (IKNA) Stock down?
We've noticed a 6.22% decline in Ikena Oncology Inc (IKNA) stock during the 2024-08-27 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
09 Nov, 2023:
Ikena Oncology Inc Stock (IKNA) dropped by 67.80% from $4.13 to $1.33 in the trading on Thursday November 9, 2023. The reasons why IKNA stock down today include:
- Q3 financials: Ikena Oncology has recently reported its Q3 revenue results, which have disappointed investors and caused IKNA stock down today. In the third quarter of 2023, Ikena Oncology experienced a net loss of USD 17.34 million, which is the same as the loss reported a year ago.
- Early data for lead asset: The October 31 readout involved seven patients with epithelioid hemangioendothelioma (EHE), a rare soft tissue sarcoma, in a dose escalation portion of an ongoing Phase I trial. While all seven EHE patients indicated stable disease as the best response, the company said three out of seven experienced tumor shrinkage.
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):